Walmart earnings, Fed meeting minutes, Zuckerberg's testimony and more in Morning Squawk

Group 1: Walmart - Walmart shares fell over 2% in premarket trading after the company's fiscal year guidance was softer than expected, with adjusted earnings per share projected between $2.75 and $2.85, below Wall Street's forecast of $2.96 [2][5] - Despite the recent dip, Walmart's stock has increased by more than 21% over the past year and nearly 175% over the last five years, reaching a market cap of $1 trillion earlier this month [5] - The company is under new leadership with CEO John Furner, who took over earlier this month, and investors are closely watching Walmart's future performance [5] Group 2: Federal Reserve - Minutes from the Federal Reserve's January meeting indicated a consensus on holding interest rates steady, but there was significant division regarding future monetary policy directions [2][3] - Some Fed members suggested that interest rates could decrease if inflation trends downward, while others believe that easing may not be necessary until clear signs of disinflation are observed [3] Group 3: Airline Industry - United Airlines announced changes to its frequent flyer program, stating that customers flying basic economy without the airline's credit card will earn fewer miles, aligning with similar moves by American Airlines and Delta Air Lines [12][13] - Cardholders will benefit from earning more points and receiving frequent flyer discounts, marking significant adjustments to the airline's loyalty program in over a decade [14] Group 4: Pharmaceutical Industry - FDA Commissioner Marty Makary warned that the U.S. is lagging behind China in early-stage drug development and suggested streamlining the process for initiating trials on new treatments [6][7] - Moderna's shares rose approximately 6% after the FDA agreed to review its experimental mRNA flu shot, reversing a previous refusal of the application [8]